Key facts
- PillTime’s last known valuation is $17.5M (Oct 2022).
- It has raised $14.1M; the latest was Later Stage VC in Jun 2025.
- Notable investors include Bluebox Capital, Business Wales Accelerated Growth Programme.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for PillTime
- ·The full record, as it builds
Funding rounds
No funding rounds for PillTime are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PillTime
Developer of medication management designed for personalized prescription delivery. The company offers pre-sorted, clearly labeled pouches, pharmacist verification, and home delivery via integration, enabling patients to simplify medication routines, improve adherence, and gain greater independence.
- Sector
- Healthcare
- HQ
- Bristol, United Kingdom
- Founded
- 2016
- Employees
- 47
- Website
- pilltime.co.uk/
- Ownership
- Privately Held (backing)
PillTime doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PillTime shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PillTime in its N-PORT filings yet. We sweep new filings monthly.